Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IDR-1002
- Development stage
- Preclinical
- Lead developer
- ABT Innovations
- Modality
- Peptides
- Administration
- Topical, Inhalation, Subcutaneous, Intramuscular, Intranasal
01
Overview
IDR-1002 is a synthetic innate defense regulator (IDR) peptide developed by ABT Innovations. It functions as a host-directed immunomodulatory agent designed to regulate innate immune responses and provide anti-inflammatory effects. Unlike traditional anti-inflammatory drugs that may cause broad immunosuppression, IDR peptides like IDR-1002 are intended to balance the immune response by selectively modulating signaling pathways. This mechanism makes it a potential candidate for adjunctive therapy in infections, as well as a treatment for asthma and other inflammatory disorders. The drug is currently in the preclinical stage of development.
- Other names
- Innate Defence Regulator 1002Innate Defense Regulator 1002
02
Targets
CCR5 (C-C chemokine receptor type 5)ITGB2 (Complement receptor 4)ITGB1 (Integrin beta-1)
Beyond the preview
Go deeper on IDR-1002.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDR-1002.